Medical Microinstruments
A developer of novel robotic solutions for unmet medical needs for microsurgery, with a teleoperated robotic platform for suturing in open surgery with wristed microinstruments.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
* | $110m | Series C | |
| Total Funding | 000k | ||
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | - | 4587 % | 63 % | 72 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | (56981 %) | (4209 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | - | (66924 %) | (6504 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
MMI Micro is a medical technology startup that operates in the healthcare sector, specifically in the field of surgical treatment. The company's primary product, Symani, is a surgical system designed to assist surgeons in performing supermicrosurgery, a highly specialized field of surgery that involves the repair of tiny lymphatic vessels. This is particularly beneficial for patients suffering from lymphedema, a condition that causes swelling in the body's tissues due to damage to the lymphatic system.
The company's market primarily consists of healthcare providers and surgeons who perform complex surgical procedures. These include surgeries related to head and neck cancer, traumatic injuries, and other conditions that require microsurgical techniques. By providing surgeons with enhanced precision and improved ergonomics, Symani aims to improve the quality of life for patients by restoring function and supporting healing.
MMI Micro operates on a business-to-business (B2B) model, selling their surgical systems to hospitals and clinics. The company generates revenue through the sales of these systems, as well as through after-sales services such as maintenance and training for the surgeons who will use the system.
In summary, MMI Micro is a medical technology startup that provides innovative solutions to surgeons, enabling them to perform complex microsurgeries with greater precision and control, ultimately improving patient outcomes.
Keywords: Medical Technology, Surgical Systems, Supermicrosurgery, Lymphedema Treatment, Head and Neck Cancer Surgery, Traumatic Injury Surgery, Precision Surgery, Ergonomic Design, B2B Sales, Patient Outcomes.